join us in W230 if you’re at #ASH25 and interested in methylation-based leukemia classification!

Looking forward to all the talks from this exciting line-up! Also grateful to have the opportunity to present our latest single-cell tech @hovestadt.bsky.social

Drs. Volker Hovestadt and Gabriel Griffin at @danafarber.bsky.social have developed a groundbreaking diagnostic tool, called MARLIN, that could transform the way acute #leukemia is identified and treated. ⚙️ Press release: https://bit.ly/4pUDBEt 🧪 Abstract: https://go.nature.com/48ea16t

A paper in Nature Genetics presents a framework for rapid acute leukemia classification that complements and enhances standard-of-care diagnostics. go.nature.com/3IInDfM #medsky 🧬 🧪

Dana-Farber's MARLIN tool uses AI to classify acute leukemia via DNA methylation in under two hours. It's not just faster; it also resolves diagnostic "blind spots" by identifying new epigenetic classes and cryptic genetic events. #MedAI #MedSky 🧬💻

Please see our new study on acute leukemia diagnostics using @nanoporetech.com methylation profiling, now out in @natgenet.nature.com ! many thanks to everyone involved !! summary by brilliant med student @til-steinicke.bsky.social below 👇

New ARTICLE now online! 'Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor–ligand interactions' ✏️By Mariella Fillbin and colleagues 🔗 www.nature.com/articles/s43...

FDA-approved FGFR inhibitors demonstrate potential as targeted therapy for embryonal tumor with multilayered rosettes, a rare and aggressive pediatric brain cancer driven by unique genetic alterations. doi.org/g9mb9g

first post on bluesky, and it's a big one: our single-cell study on ETMR, a terrible brain tumor that occurs in young children, now out in @natcancer.nature.com: www.nature.com/articles/s43.... tremendous effort by @alexbeck, @lisagblr.bsky.social and many others. please check it out!